Towards health for all in the Year of Corona: our highlights of 2020

What did Wemos do for global health in the year that global health was under severe threat? We advocated the sharing of knowledge on Covid-19 vaccines, raised awareness on the risks of commerce in health, developed a new programme on health worker mobility in Europe, and much more. Check the highlights of our advocacy work in 2020 in our interactive overview.

The year 2020 will forever be remembered as the year of the Covid-19 pandemic. It has impacted lives all over the world. It has also clearly exposed the inequities that still exist in global health. Thus, the pandemic relates to all the goals we strive for at Wemos: equal access to medicines, sufficient investments in health, and well-trained and motivated health workers.

Like everyone, we had to adjust our day-to-day business by switching to remote working and online events and meetings. Despite the challenges, we seized advocacy opportunities to get our message and policy recommendations across. The past pandemic year therefore brought us many notable highlights, as you can see in our new interactive ‘Highlights 2020’ (see also bottom of this page).

Access to Medicines
Within our programme on Access to Medicines, we advocated the sharing of knowledge of Covid-19 technologies to ensure the rapid development and production of diagnostics, vaccines, and treatments for everyone in the world, not only the richest countries. We discussed this in various debates and media, and continued our involvement in the debate around public return on public investments.

Finance for Health
Through our work on Finance for Health, we successfully advocated improvements in the new strategy of the Global Financing Facility (GFF), leading to increased civil society involvement, attention for intersectionality, and more transparency. We also raised awareness about the risks of strengthening commerce in health, through discussion papers and contributing to a focus group discussion on the Dutch Aid & Trade agenda.

Human Resources for Health
Our focus on Human Resources for Health led to a new programme on health worker mobility in the European region, with Wemos as lead organisation. We also elicited engagement and major global health donors’ views on the importance of investing in human resources for health; 143 civil society organisations signed our letter, and many donors responded as well. We will continue the dialogue.

Have a look at our new interactive ‘Highlights 2020’ overview to read more about last year’s successes. We hope that 2021 will bring positive changes in global health. Wemos is ready for the new year!

Note: the publication is best viewed in fullscreen mode. Please click on the three dots below or click this link.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News items

Research shows Moderna’s triple jackpot: subsidies, high prices and tax avoidance


Research by SOMO in cooperation with Wemos reveals that Covid-19 vaccine manufacturer Moderna avoids taxes on the profits it generates with billions of public funding. First the pharmaceutical company receives government subsidies for the development of its vaccine, then it sells the vaccines to governments for high prices, and in the end it transfers the majority of the profits to tax havens. Wemos and SOMO urge governments to attach conditions to public investments in development of vaccines and medicines, to ensure the accessibility and affordability of these products.

Continue reading